NCT01900522: Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia |
|
|
| Terminated | 1 | 76 | US | ITI-214 Dose A, ITI-214 Dose B, ITI-214 Dose C, ITI-214 Dose D (Elderly), Placebo, ITI-214 Dose E, ITI-214 Dose F, ITI-214 Dose G, ITI-214 Dose H | Takeda, Intra-Cellular Therapies, Inc. | Schizophrenia | 09/14 | 12/14 | | |
NCT03489772: Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement |
|
|
| Completed | 1 | 26 | US | ITI-214, Placebo | Intra-Cellular Therapies, Inc., Laureate Institute for Brain Research, Inc. | Healthy Volunteers | 08/19 | 08/19 | | |
